News for 'Post Sun Pharma'

Torrent Pharma Q3 net at Rs 14.26 cr

Torrent Pharma Q3 net at Rs 14.26 cr

Rediff.com23 Jan 2003

Torrent Pharmaceuticals Ltd has posted a net profit of Rs 142.60 million for the quarter ended December 31, 2002 as compared to net loss of Rs 276.60 million in the quarter ended December 31, 2001.

Sun Pharma Q3 net at Rs 55.86 cr

Sun Pharma Q3 net at Rs 55.86 cr

Rediff.com30 Jan 2003

Sun Pharmaceutical Industries Ltd has posted a net profit of Rs 558.60 million for the quarter ended December 31, 2002 as compared to a net profit of Rs 464.10 million in the corresponding period last fiscal.

'Invest in mid-caps very selectively'

'Invest in mid-caps very selectively'

Rediff.com25 Sep 2018

Even as rising crude oil prices, trade war fears and a sliding rupee cast a shadow on market sentiment, Nischal Maheshwari, chief executive officer for institutional equities and advisory at Centrum Broking, tells Puneet Wadhwa that in the next one year, the outcome of the 2019 general election is a bigger challenge for the market.

Sensex rallies 281 points, Nifty closes above 11k-mark

Sensex rallies 281 points, Nifty closes above 11k-mark

Rediff.com13 Sep 2019

Top gainers in the Sensex pack included Vedanta, ICICI Bank, ONGC, Kotak Bank, Axis Bank, SBI, M&M, Infosys, PowerGrid, HCL Tech, NTPC, Bajaj Finance and Reliance Industries, rising up to 2.72 per cent.

11 killed after giant crane collapses at Visakhapatnam shipyard

11 killed after giant crane collapses at Visakhapatnam shipyard

Rediff.com1 Aug 2020

TV visuals showed the giant crane falling on the ground with a loud thud.

Revealed! The top JOBS of 2020

Revealed! The top JOBS of 2020

Rediff.com30 Dec 2020

Naukri.com's Hiring Outlook Survey for 2020 reveals the jobs and sectors that saw a surge in demand during the pandemic.

Markets stage strong comeback; log 5th weekly gains

Markets stage strong comeback; log 5th weekly gains

Rediff.com22 Jun 2018

Sun Pharma stole the show in the Sensex pack, spurting 3.91 per cent, followed by M&M at 2.87 per cent.

'I want to make Rs 1 crore in 17 yrs'

'I want to make Rs 1 crore in 17 yrs'

Rediff.com7 Jan 2022

Omkeshwar Singh, head, Rank MF, a mutual fund investment platform, answers your queries.

MF GURU: Mutual funds you must buy, hold or exit NOW

MF GURU: Mutual funds you must buy, hold or exit NOW

Rediff.com14 Dec 2021

Omkeshwar Singh, head, Rank MF, a mutual fund investment platform, answers your queries.

Prices of key diabetes, cancer drugs may drop by 25%

Prices of key diabetes, cancer drugs may drop by 25%

Rediff.com8 Mar 2018

A recent report has suggested that future patent expires in the cardiac and anti-diabetes space would form a good opportunity for smaller firms, given their franchise in these segments.

States want GST exemption on Remdesivir, others

States want GST exemption on Remdesivir, others

Rediff.com19 Apr 2021

Other decisions piled up include rationalisation of GST rate slabs, correction of inverted duty on certain items and inclusion of petroleum products.

September may see end of IPO drought with 5 hitting the market

September may see end of IPO drought with 5 hitting the market

Rediff.com3 Sep 2020

Many are now hoping the markets remain in good stead as they look to finalise the dates for IPOs, such as UTI MF, Computer Age Management Services, Happiest Mind, and Angel Broking. Most of the issues are expected to come to the market in the second half of September.

High commodity prices hit India Inc's profits, margins

High commodity prices hit India Inc's profits, margins

Rediff.com17 Aug 2021

After the hit of the pandemic, India Inc is now worried about the adverse impact of inflation and higher commodity prices on their revenues and margins. The inflation scare is the strongest among manufacturers of consumer goods such as automobiles, consumer durables, and fast-moving capital goods (FMCG). Companies across sectors fear they will not be able to pass on the hike in input costs to their consumers due to weak demand, which, in turn, would lead to a hit on margins and profitability in the forthcoming quarters.

10 things that will make 2021 different!

10 things that will make 2021 different!

Rediff.com10 Jan 2021

From 5G to Tesla to Covid vaccine, 10 things will shape India's future.

What is Biden trying to tell India?

What is Biden trying to tell India?

Rediff.com30 Jul 2021

It is difficult to recall an Indian minister in modern times pushing back at the US publicly, observes Ambassador M K Bhadrakumar.

Markets extend winning streak as finance, IT stocks zoom

Markets extend winning streak as finance, IT stocks zoom

Rediff.com20 Jul 2020

On the Sensex chart, Bajaj Finance, Bajaj Finserv, HCL Tech, Tech Mahindra, Infosys, HDFC Bank and ICICI Bank were among the prominent gainers.

Between BJP and 2nd term in Uttarakhand stands Covid

Between BJP and 2nd term in Uttarakhand stands Covid

Rediff.com19 Jun 2021

As the virus ravaged rural areas, the state BJP figured out it was impossible to underplay or escape its impact on its political plans.

Share of family-owned firms in total market capitalisation rises to 64.5%

Share of family-owned firms in total market capitalisation rises to 64.5%

Rediff.com4 Jan 2021

The growth was led by family-owned companies and business groups with presence in pharmaceuticals, information technology services, and consumer products.

10 HOT careers for IT grads

10 HOT careers for IT grads

Rediff.com15 Apr 2021

Engineering graduates specialising in artificial intelligence and machine learning can earn up to 24 lakh a year, says Saran Balasundaram, founder and CEO, HanDigital, a talent consulting firm.

Why reopening LoC trade routes remain a pipedream for Kashmir traders

Why reopening LoC trade routes remain a pipedream for Kashmir traders

Rediff.com26 Apr 2019

The chances of the posts opening remain slim, with security agencies recently identifying 10 suspects who smuggled in weapons, narcotics and fake currency.

Sun gets US trade regulator nod for Ranbaxy merger

Sun gets US trade regulator nod for Ranbaxy merger

Rediff.com1 Feb 2015

Torrent to buy Ranbaxy's anti-bacterial generic

Sensex, Nifty end last session of 2016 in green

Sensex, Nifty end last session of 2016 in green

Rediff.com30 Dec 2016

An expectation of tax sops in Budget, weakness of dollar and robust tax collection are adding positive sentiment

Serum gets nod for phase 2, 3 trials of Covid vaccine in India

Serum gets nod for phase 2, 3 trials of Covid vaccine in India

Rediff.com3 Aug 2020

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

Sensex, Nifty end almost flat; falling rupee a concern

Sensex, Nifty end almost flat; falling rupee a concern

Rediff.com13 Aug 2015

Banking shares saw a renewed buying interest on the hopes of a rate-cut by the central bank post the easing of macro-economic data.

Stocks that shine year after year

Stocks that shine year after year

Rediff.com31 Dec 2014

The S&P BSE Sensex has rallied about 28 per cent in 2014, after formation of a stable government at the Centre.

Drug patent row: HC to hear US co on Apr 12

Drug patent row: HC to hear US co on Apr 12

Rediff.com10 Apr 2013

A bench of justices Sanjay Kishan Kaul and Indermeet Kaur took the plea of US pharma major on record and posted it for hearing before another bench on April 12.

COVID presents an opportunity for India: Tata's Chandra

COVID presents an opportunity for India: Tata's Chandra

Rediff.com12 Jun 2020

The Tata Sons' chief said that world's reliance on China for sourcing goods will reduce, and India will definitely have an opportunity to participate.

No possibility of GST rate hike till revenue stabilises: Sushil Modi

No possibility of GST rate hike till revenue stabilises: Sushil Modi

Rediff.com23 Dec 2019

Bihar Deputy Chief Minister Sushil Kumar Modi said, a hike in GST rates would have hampered consumption amid the economic slowdown. The revenue augmentation panel in the Council meeting recently recommended revisiting and restructuring the GST rate slabs, besides correcting the inverted duty structure. The panel listed 24 items, including mobile phones, footwear, fabrics, LED light, medical equipment, utensils, agri machinery, pharma, and renewable components, which have an inverted duty structure, resulting in refunds of close to Rs 20,000 crore annually.

Nearly 50% BSE 500 stocks underperform market since March low

Nearly 50% BSE 500 stocks underperform market since March low

Rediff.com25 Sep 2020

The S&P BSE 500 index, which accounts for 94% market capitalisation of BSE listed companies, has gained 45% from its March 24 low. However, out of the BSE 500 index stocks, 225 have underperformed the index by gaining less than the broader index during this period.

'Can't book profits in stock markets. Need help'

'Can't book profits in stock markets. Need help'

Rediff.com7 Dec 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Infy leads rally on BSE, Sensex up 160 pts

Infy leads rally on BSE, Sensex up 160 pts

Rediff.com15 Jul 2019

Infosys was the top gainer in the Sensex pack, closing 7.20 per cent higher as investors cheered its financial results. The IT major posted better-than-expected 5.3 per cent rise in its June quarter net profit, and raised revenue growth forecast for the current fiscal.

Sensex rises 145 points to end at fresh 2016 high

Sensex rises 145 points to end at fresh 2016 high

Rediff.com1 Jul 2016

n the broader market, both the BSE Midcap and Smallcap indices, were up 1.2% and 0.7% each.

Markets end lower on May F&O expiry; Sensex sheds 58 points

Markets end lower on May F&O expiry; Sensex sheds 58 points

Rediff.com28 May 2015

Sensex eneded lower on poor perfromance by financials and IT stocks.

Festive delight for employees as firms begin to roll back salary cuts

Festive delight for employees as firms begin to roll back salary cuts

Rediff.com30 Oct 2020

HR experts estimate that up to 70 per cent companies in the manufacturing and services space including sectors like auto components, edutech and construction equipment are looking to restore the salary cuts over the next couple of months.

Strong US growth to boost pharm cos' fortune in FY14

Strong US growth to boost pharm cos' fortune in FY14

Rediff.com12 Jun 2013

Revival in domestic business should also help overall revenue growth.

How to invest in markets after Friday's BLOODBATH

How to invest in markets after Friday's BLOODBATH

Rediff.com1 Mar 2021

'You can put 25 per cent right now; put another 25 per cent when Nifty corrects another 500 points.' 'At 13,500 put another 25 per cent and at 13,000 one can get fully deployed.'

Best and worst performing stocks in 2015

Best and worst performing stocks in 2015

Rediff.com30 Nov 2015

Natco Pharma, Wockhardt and Marksans have rallied between 50 and 70 per cent in the year till date.

What Brought Economy to Its Knees

What Brought Economy to Its Knees

Rediff.com12 Aug 2021

A combination of demonetisation, a poorly and hurriedly implemented GST, and more recently the "botched up" lockdown of the economy to control the spread of Covid has brought the economy to its knees.

Uptick in hiring activities in October

Uptick in hiring activities in October

Rediff.com9 Nov 2020

With economic activities gathering pace post easing of lockdowns across the country, hiring activities in most sectors have shown significant recovery in October over the previous month, says a report. On yearly basis, however, the overall hiring was down by 17 per cent in October, according to the Naukri JobSpeak Index for October' 2020.

Ranbaxy Q4 net loss at Rs 73.6 crore

Ranbaxy Q4 net loss at Rs 73.6 crore

Rediff.com9 May 2014

It had posted net profit of Rs 125.75 crore (Rs 1.25 billion) during the January-March quarter of the previous fiscal, 2012-13.